Helping Entrepreneurs Achieve Success
Are you a MedTech, Health or Wellbeing entrepreneur with plans to scale your business? Do you need guidance and practical support to turn your vision into a commercial reality?
Australian Health Accelerator (AHx) Program
The Australian Health Accelerator (AHx) program is a catalyst for validating and commercialising new, innovative health related products and services with access to state-of-the-art facilities, simulation suites and laboratories.
Whether you have a great idea that needs to get off the ground or you’re already trading and looking to scale up, this program steers your venture in the right direction with tried and tested industry specific tools, resources and international connections. The AHx program is the region’s first health and wellbeing accelerator. The Innovation Centre will find, fund and accelerate 10 ambitious businesses in the region, giving them the skills, connections and opportunities they need to take their business to the next level.
When and Where
WHEN: September 2019
WHERE: Sunshine Coast Health Institute
FACILITATOR: Innovation Centre Sunshine Coast
WHY THE SUNSHINE COAST:
Australia is home to some of the most exciting health related research and clinical innovations in the world and represents tremendous growth potential for local business. With our IC capability, $5Billion Sunshine Coast Health Precinct and other competitive advantages – the Sunshine Coast is the ideal location for AH-x.
Support from our partners
Healthtech Innovation QLD
“We are pleased to partner with the Sunshine Innovation Centre to support Queensland’s first health and wellbeing accelerator. There is a need for specialized scaling and commercialization of innovative health and medical technologies in the region to address challenges such as our aging population and increasing chronic disease rates. The AHx program will enable local health and welling start-ups to accelerate and boost their potential to improve health outcomes and transform healthcare in the region and beyond.” Tamara Mills, Director
Sunshine Coast Health Institute
“The AHx program will help drive a culture of innovation at the SCHI, whilst also providing capacity building for health-related entrepreneurs to validate and commercialise new, innovative products in one of the newest and most advanced hospitals in the world.” Anton Sanker, Director.
What you will achieve
Submit Your Application Now for 2019
Join the IC’s medtech, health and wellbeing accelerator program based in the heart of the $5.3B Sunshine Coast Health Precinct.
Frequently Asked Questions
About the Sunshine Coast Health Industry
The Health and Wellbeing industry is the Sunshine Coast’s largest employer with approximately 1,700 healthcare businesses in operation and about 21,000 people working in the sector. This industry is also one of the largest generators of economic activity in the region and predicted to double its share of the employment market by 2033.
Health Research at the University of the Sunshine Coast
Within the broad field of human health, USC researchers work across four broad research themes:
Optimising Health and Combating Disease
Innovative Health Technologies
USC’s research has a strong focus on delivering innovative, effective health solutions and improved health outcomes in regional and outer metropolitan communities. USC's researchers are embedded with industry partners in the areas of drug discovery, medical device development and implementation, health services re-design and health professional workforce development.
Ms. Tamara Mills is Managing Director of Quantum Innovation Fund Management, a high caliber innovation commercialization organization, supporting the growth and development of the Australasian health innovation ecosystem and facilitating strategic investments in the equity and equity-linked securities of early to mid-stage companies involved in the development of breakthrough medical and healthcare technologies. Tamara is also CEO of the Australian Start-up company disrupting emergency medicine - De Motu Cordis.
Tamara Mills previously managed Jubilant Lifesciences portfolio of pipeline assets and has extensive experience in the development and commercialisation of medical technologies across Australia, Unites States, Japan, Brazil and Europe having held executive roles within both publicly listed and private companies. Prior to returning to Australia, Tamara held the position as Director of Cardiovascular Business for Jubilant Life Sciences, where she successfully built the cardiovascular business from the ground up and led the development of multiple medical technology products from concept through to FDA approval and commercialization.
Tamara Mills has founded a range of medical technology businesses in Australia and North America and has had broad experience with accelerators, bootcamps and incubator programs across Australia and North America having founded and facilitated Fundamedtech, Canadas first complex Medtech Incubator, and mentored/coached in programs including CSIRO biomedical launchpad, McGill-X1, Hacking Health and MIT Entrepreneurship Bootcamps. Tamara is currently working with the Massachusetts Institute of Technology (MIT) Innovation and entrepreneurship faculty, coaching start-ups within the life-sciences sector.
Tamara has held several board positions in the health technology sector and she is active in the field of diagnostic and therapeutic technology development, most recently held the position of Chair of the Health Policy, Regulatory and Reimbursement committee for the North American Industry organization CORAR in addition to holding a key leadership role for the Medical Imaging Technology Alliance. Tamara has a Masters in Business Administration, Masters in Health Economics and Pharmacoeconomics and a Degree in Applied Nuclear Physics.